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a  b  s  t  r  a  c  t
Background:  During  outbreaks  of  infectious  diseases,  transmission  of  the  pathogen  can  form  networks  of
infected  individuals  connected  either  directly  or  indirectly.
Methods:  Network  centrality  metrics  were  used  to  characterize  hospital-acquired  Middle  East  Respiratory
Syndrome  Coronavirus  (HA-MERS)  outbreaks  in  the  Kingdom  of  Saudi  Arabia between  2012  and  2016.
Covariate-adjusted  multivariable  logistic  regression  models  were  applied  to assess  the  effect  of individual
level  risk  factors  and network  level  metrics  associated  with  increase  in  length  of  hospital  stay  and  risk  of
deaths  from  MERS.
Results: About  27%  of  MERS  cases  were hospital  acquired  during  the study  period.  The  median  age  of
healthcare  workers  and  hospitalized  patients  were  35 years  and  63  years,  respectively,  Although  HA-
MERS were  more  connected,  we found  no  significant  difference  in degree  centrality  metrics  between
HA-MERS  and  non-HA-MERS  cases.  Pre-existing  medical  conditions  (adjusted  Odds  ratio  (aOR)  =  2.43,
95%  confidence  interval:  (CI)  [1.11–5.33])  and hospitalized  patients  (aOR  =  29.99, 95%  CI [1.80–48.65])
were the  strongest  risk predictors  of  death  from  MERS.  The  risk  of  death  associated  with  1-day  increased
length  of  stay  was  significantly  higher  for patients  with  comorbidities.
Conclusion:  Our  investigation  also  revealed  that  patients  with  an  HA-MERS  infection  experienced  a  sig-
nificantly  longer  hospital  stay  and  were  more  likely  to die  from  the  disease.  Healthcare  worker  should  be
reminded  of their  potential  role  as hubs  for pathogens  because  of  their  proximity  to  and  regular  interac-
tion  with  infected  patients.  On  the other  hand,  this  study  has  shown  that while  healthcare  workers  acted
as  epidemic  attenuators,  hospitalized  patients  played  the  role  of an epidemic  amplifier.
©  2018  The  Authors.  Published  by Elsevier  Limited  on  behalf  of King  Saud  Bin Abdulaziz  University
for  Health  Sciences.  This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://
creativecommons.org/licenses/by-nc-nd/4.0/).ntroduction
Middle East Respiratory Syndrome Coronavirus (MERS) is trans-
itted via interactions among individuals. The danger of infection
s highest for groups of individuals living in close proximity. From
he intermittent transmission that occurred in animal-to-human,
any human-to-human cases of MERS have also been docu-Please cite this article in press as: Adegboye O, et al. Individual and n
East Respiratory Syndrome coronavirus. J Infect Public Health (2018),
ented within family and healthcare facilities [1–3]. Transmission
f MERS pathogen can form networks of infected individuals that
ere connected either directly or indirectly. One should expect in
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C  BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).such environments the formation of large clusters of infections as
observed during the outbreak in the Kingdom of Saudi Arabia (KSA)
[4] and South Korea (SK) [5]. Cluster size of human-to-human trans-
missions of MERS has been shown to vary and a high variability and
heterogeneity in the transmission potential have been underscored
[6,7].
The first case of the Middle East Respiratory Syndrome Coro-
navirus (MERS-CoV) was reported in 2012. By February 2018, a
total of 2182 laboratory-confirmed MERS-CoV infections had been
reported to the World Health Organization (WHO) [8]. The dis-
ease has now spread to over 27 countries with most index patientsetwork characteristic associated with hospital-acquired Middle
 https://doi.org/10.1016/j.jiph.2018.12.002
either residing or recently traveling to areas neighboring the Ara-
bian Peninsula [9,10]. Similarly, the vast majority of the total cases
(82%) occurred in KSA [8]. The global mortality rate was  highest
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58%) at the beginning of the epidemics (September 2012–February
013) and it dropped continuously to an absolute low of 23% during
eptember 2015–February 2016. As of February 2018, these infec-
ions has led to 779 documented deaths (a mortality rate of 36%)
8]. People within the age-group 50–59 years are at the highest risk
f being infected as primary cases and have the highest mortality
ate [8]. Forty-five day survival rate was lowest in patients older
han 65 years (44.86%) [11]. Also, healthcare workers (HCW) are
egularly exposed to MERS due to their regular contacts with MERS
atients and are at greater risk of being infected; however, they are
ess likely to die of the disease [10,12–14].
Strong links between healthcare facilities and the spread of
he MERS disease have been found in KSA, where the major-
ty of patients were in contact with other patients at healthcare
acilities [15–18]. Unfortunately, this phenomenon is widespread
nd well-known as nosocomial infections (hospital-acquired infec-
ions) which occur frequently with surgical-site infections (SSIs),
neumonia and gastrointestinal infections among the top hospital-
cquired infections (HAIs) [19,20].
There has been a number of documented outbreaks of MERS
nfection within clusters of healthcare facilities among hospital-
zed patients and healthcare worker [15,17,18]. In 2015, cases of
ERS were reported in SK when the index patient returned from
is trip to the Arabian Peninsula where he had contracted MERS
18]. The disease spread out across various cities in SK within
wo months, expanding from one to 17 hospitals and infecting a
otal of 186 people. Similarly, a major MERS outbreak was  reg-
stered at a tertiary-care hospital in Riyadh in 2015 [4,17,21,22].
he escalation of the Riyadh outbreak was linked to extended
ealthcare-related human-to-human transmissions [4,17,21,22].
hese outbreaks were attributed to few index cases and the level
f their spreading depended on interactions between individuals.
or example, 82 out of the 186 infected patients in SK were traced
ack to one index patient alone due to the overcrowded emergency
oom with patients, visitors and healthcare worker [23].
This study focused on cases of hospital-acquired MERS (HA-
ERS) in Saudi Arabia. The objectives of this study were to explore
he structure of transmission networks formed by these out-
reaks in order to describe its routes and the relationship between
atients’ characteristics and the disease network metrics. Specif-
cally, we will investigate the effects of place of exposure in the
ransmission mechanisms of MERS, whether outbreaks in the hos-
ital vs. outbreaks elsewhere in the community have significant
ifferences in the length of hospital stay (LOS). Similarly, we  esti-
ate the risk of death associated with MERS diseases between
A-MERS and non HA-MERS.
aterials and methods
ata source
The data for this study was based on laboratory confirmed and
robable cases of MERS-CoV infection in the KSA between 2012
nd 2016 from various sources such as WHO  bulletins, media
eports and Kingdom of Saudi Arabia Ministry of Health (MoH), and
btained from the case-by-case list compiled and maintained by Dr.
ndrew Rambaut [24]. The data sets were also assessed for accuracy
ith those reported by Flu Trackers, KSA MoH  and WHO. The data
ontains information on patient demographics, clinical outcome,
hether the patient was a healthcare worker (HCW), comorbidity
tatus of the patient, and place of exposure to known risk factors.Please cite this article in press as: Adegboye O, et al. Individual and n
East Respiratory Syndrome coronavirus. J Infect Public Health (2018),
e used the following approaches to estimate length of hospital
tay (LOS): (1) we restricted our analysis to those patients who are
till alive and those that died within 60 days for short-time risk of
eath analysis (2) LOS was calculated as the difference between the PRESS
d Public Health xxx (2018) xxx–xxx
date of onset of disease (or date reported whenever date of onset
was not available) and date of death/discharged.
Study population and definitions
The study population consisted of patients with confirmed
MERS infection. The cases were confirmed via real-time RNA-
positive using Reverse transcription polymerase chain reaction
(RT-PCR) showing positive PCR on at least two specific genomic tar-
gets upstream E protein (upE) and ORF1a or a single positive target
(upE) with sequencing of a second target (RdRpSeq assay) or N gene
(NSeq assay) [25]. Overall, 787 patients with known contact history
to identify the place of exposure which was  classified as HA-MERS
or non HA-MERS were included in this study. A MERS infection is
described as hospital acquired (HA-MERS) if the patient has contact
with confirmed patients (alive or deceased) or healthcare work-
ers, or healthcare facilities which had MERS-CoV outbreak while
non HA-MERS were those acquired elsewhere such as community,
household/family [26].
Statistical analysis
The data was analysed in three stages. First, descriptive statistics
were presented as medians and interquartile range for contin-
uous variables, and frequencies and percentages for categorical
variables. Odds ratios (OR) together with their 95% confidence
interval were also used for categorical variables. The chi-square test
was used to compare patient’s attributes (categorical variables) for
those infections acquired in the hospital and those acquired else-
where in the community while the Mann-Whitney U-test was used
to compare continuous attributes (continuous variables).
In the second stage, the unit of analysis for the networked
data were the nodes representing individuals infected with MERS.
In network analysis, the nodes (individual patients) have distin-
guishable attributes such as age, gender, etc., while interactions or
relationships between nodes are called edges or links [27]. A net-
work can be defined as a collection of nodes connected by edges
where nodes and/or edges have attributes [28]. Each patient (node)
was assigned a unique identification number and his/her contact
history was  tracked within 14 days of the onset of the disease. MERS
patients who  were in contact with other laboratory-confirmed
MERS patients were identified and a list of each patient-contact
pair (dyad) was prepared. A dyad is a linked pair of patients (nodes)
in the network that is the fundamental unit for deriving network
metrics. The outbreak network visualization and network analy-
sis were conducted in UCINET 6.0 Version 1.00 [29]. The following
centrality metrics were used to measure the structural importance
of patients (nodes) in a network. “Degree centrality” was  used to
reveal the most active nodes in the network and how well a node
is connected with its neighbours — a node degree is the number of
edge incidents on a node; the “betweenness centrality” was used
to measure how many pairs of nodes a node can be connected to
through a shortest path while “eigenvector centrality” was used to
measure the importance of a node depending on the importance of
its neighbours [27,29].
In the final analysis, a covariate-adjusted multivariable logis-
tic regression model was used to assess the effects of individual
level risk factors and network level metrics (patients nested within
networks) on risk of deaths from MERS between HA-MERS and non-
HA-MERS patients. Similarly, we used a generalized linear modeletwork characteristic associated with hospital-acquired Middle
 https://doi.org/10.1016/j.jiph.2018.12.002
to identify disease-risk factors associated with the increase in the
length of stay (LOS) between HA-MERS and non-HA-MERS patients.
We  used stepwise selection to select the variables for inclusion
in the regression models. All statistical analyses were conducted in
ARTICLE IN PRESSG ModelJIPH-970; No. of Pages 7
O. Adegboye et al. / Journal of Infection and Public Health xxx (2018) xxx–xxx 3
Table  1
Characteristics of HAI-MERS and non-HAI-MERS cases in Saudi Arabia between June 2012 and September 2016. Number of cases (%) or median (IQR).
Variables Hospital-acquired Acquired elsewhere p-value Odds-ratio (95% C.I.)
N = 378 N = 409
Age 47 (33–64) 46 (31–60) <0.0860 1.01 (1.00, 1.02)
Length  of staya 19 (13–29) 14 (10–19) <0.0001 1.02 (1.00, 1.03)
Gender
Male  200 (52.9%) 287 (70.2%) <0.0001 2.04 (1.53, 2.74)
Female 176 (46.6%) 121 (29.6%) Ref
Unknown 2 (0.5%) 1 (0.2%)
Comorbidity
Presence 225 (69.5%) 204 (48.8%) <0.0001 1.88 (1.43, 2.48)
Absence 94 (24.9%) 77 (18.8%) Ref
Unknown 59 (15.6%) 128 (31.3%)
Outcome
Fatal 125 (33.1%) 100 (24.4%) <0.0001 1.53 (1.12–2.08)
Non-fatal 253 (66.9%) 309 (75.6%) Ref
Healthcare worker (HCW) 166 (43.9%)
a The length of stay was calculated as difference between: date of onset of symptoms and date discharged or date of death.
Table 2
Descriptive summaries (and unadjusted odds ratio) for cases of hospital acquired MERS infection among different groups. Number of cases (%) or median (IQR).
Risk factors Place of infection Total (N = 378)
Healthcare workers Hospitalized patient Hospital visitor Fatal Non-fatal Odds-ratio (95% C.I.)
N = 166 (43.9%) N = 194 (51.3%) N = 18 (4.8%) N = 125 (33.1%) N = 253 (66.9%)
Age 35 (28–44) 63 (51–75) 44 (38–60) 68 (54–77) 39 (30–54.5) 1.06 (1.05, 1.08)
Length  of stay 16 (12–25) 39 (17.75–7.75) 12 (9–16) 18 (10.3–28) 17 (12.5–26) 1.02 (1.00–1.03)
Gender
Male  102 (61.5%) 127 (65.5%) 11 (61.1%) 83 (66.4%) 117 (46.3%) 2.26 (1.46, 3.56)
Female  62 (37.3%) 67 (34.5%) 7 (39.95%) 42 (33.6%) 134 (53%)
Unknown 2 (1.2%) 0 0 2 (0.8%)
Comorbidity
Presence 32 (45.8%) 182 (93.8%) 11 (61.11) 117 (93.6%) 108 (42.7%) 19.28 (8.30, 56.29)
Absence 76 (45.7%) 11 (5,67%) 7 (38.9) 5 (4.0%) 89 (35.1%)
Unknown 58 1 (0.51) 0 23(2.4%) 56 (22.1%)
Mortality N (%)
Fatal 5 (3%) 119 (61.3%) 1 (5.6%)
























4OR  (95%CI) Ref 31.1 (22.05, 48.95) 1.89 (
AS 9.3 Software Version 6 of the SAS System for Windows [30] and
nference was at 5% level of significance.
esults
Overall 787 cases were included in this study. There were
78 (48%) cases of HA-MERS infection while 409 (52%) cases
ccurred elsewhere in the community, for instance within house-
olds (Table 1). Three different HA-MERS groups were defined
ased on their type of exposure: (1) Healthcare worker, (2) Hospital
isitors, (3) Hospitalized patients. The demographic characteristics
f the infected patients are presented in Table 1. Patients with
A-MERS had significantly longer stays in the hospital (Median
Med) LOS = 19 days, Interquartile range (IQR) = 13–29) compared
o non-HA-MERS (Med. LOS = 14 days, IQR = 10–19). One hundred
nd twenty-five (33.1%) of the HA-MERS cases died during their
ospital stay while 100 (22.4%) of the non-HA-MERS cases died
uring their treatment in the hospital. There was  no significant
ifference between the median age of HA-MERS and that of non-
A-MERS, 47 years (33.0–64) vs. 46 years (31–60) in Table 1;
owever, age among healthcare workers, hospitalized patients and
ospital visitors differed significantly (Table 2). The overall crudePlease cite this article in press as: Adegboye O, et al. Individual and n
East Respiratory Syndrome coronavirus. J Infect Public Health (2018),
atality rate (CFR) was 32%, with significantly higher CFR in HA-
ERS cases (33.1%) than among non HA-MERS (24.4%) (Table 1).
imilarly, 69.5% of HA-MERS patients had comorbidities against
8.8% of non-HA-MERS patients (Fig. 1).2.68)
Male patients were more likely to have HA-MERS infection com-
pared to females (unadjusted odds ratio (OR) = 2.04, 95% confidence
interval (CI), [1.53–2.74]). There were slightly more patients with
comorbidities among HA-MERS (69.5%) than non-HA-MERS (48.8%)
(P-value <0.0001). Patients with comorbidities were twice likely to
have HA-MERS than patients without comorbidities (OR = 1.88, 95%
CI [1.43–2.48]). Similarly, being a healthcare worker and of older
age significantly increased the odds of having a HA-MERS infec-
tion (Table 1). Patients with longer hospital stays were significantly
more likely to have an HA-MERS than non-HA-MERS (OR = 1.02, 95%
CI [1.00–1.03]).
Table 2 presents the descriptive summaries of the HA-MERS
cases and unadjusted odds ratio for mortality due to MERS.
Although those patients who died of MERS disease were signif-
icantly less likely to have HA-MERS infection than those with
non-fatal health outcome (Table 1), place of infection signifi-
cantly influenced mortality from MERS disease among HA-MERS
patients with greater risk for hospitalized patients (OR  = 31.1, 95%
CI [22.05–48.95[).
In the unadjusted analysis in Table 2, the likelihood of fatality
from MERS disease increased proportionally with age by a fac-
tor of 6% for every unit increase, fatal cases in male HA-MERS
patients were more likely than fatal cases in female HA-MERSetwork characteristic associated with hospital-acquired Middle
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patients (OR = 2.26, 95% CI [1.46–3.56]). Among the 378 HA-
MERS cases, comorbidities were recorded in 225 (69.5%) cases out
of which 117 cases were fatal. HA-MERS patients with comor-
bidities were at a significantly higher risk of death from MERS
ARTICLE IN PRESSG ModelJIPH-970; No. of Pages 7

































Cig. 1. Distribution of weekly number of MERS cases by week of symptom onset a
ospitalized or date the disease is reported was  used (whichever comes first).
isease than patients with no comorbidity (OR = 19.28, 95% CI
8.30–56.29]).
ransmission network
The network structure of HA-MERS infection is presented in
ig. 2 together with the degree centrality metrics. Because these
etwork centrality metrics were highly correlated, we  shall limit
ur focus to degree centrality. The network density of HA-MERS
as 0.019 (1.9%) with an average degree of 1.8 contacts. Greater
egree centrality was associated with increased risk of death from
ERS. Our results suggest that healthcare workers have on average
ignificantly lower degree centrality scores than non-healthcare
orkers. Although HA-MERS were more connected, we have found
o significant difference in degree centrality between HA-MERS
nd non HA-MERS cases. Patient’s transmission degree central-
ty was significantly negatively correlated with age. As depicted
n Fig. 2, the larger node size represents the prioritized patients
1664, 124, 1025, 133, 897, 898) based on the degree centrality
etrics because they have the most ties to other patients within
he network.
ength of stay and risk of death
On the basis of unadjusted analysis, HA-MERS, hospitalized
atients, older patients and patients with comorbidities were pos-
tively associated with length of hospital stay while being HWC
as a negative association. Results from further investigation of
he associated risk factors for increased LOS among MERS patients
fter controlling for other risk factors revealed that only patients
ith comorbidities significantly increased the length of hospital
tay (Table 3).
Table 4 shows the estimated risk of death associated with each
atient’s characteristics used in this study. The adjusted analysis
ndicates that comorbidity, HCW, hospitalized patient, hospital vis-Please cite this article in press as: Adegboye O, et al. Individual and n
East Respiratory Syndrome coronavirus. J Infect Public Health (2018),
tor, age and LOS were significantly associated with risk of mortality
rom MERS.
In the model, patients with comorbidities (OR = 2.43, 95%
I [1.11–5.33[) and hospitalized patients (OR = 29.93, 95% CI number of HA-MERS in KSA. Wherever the date of onset is not available, the date
[1.80–48.65]) were the strongest risk predictors of mortality from
MERS.
Between HA-MERS infections and non HA-MERS infections, the
effect of one-day increase in LOS on risk of death after adjusting for
several predictors is illustrated in Table 5. We  have found that when
age alone was in the model, there was a significant increase in risk
of death between HA-MERS and non HA-MERS. After controlling
for age and comorbidities, we  found that risk of MERS mortality
were significantly higher in patients with HA-MERS compared with
patients without HA-MERS (OR = 4.41, 95% CI [1.29–14.98]).
Discussion
Preventing the spread of emerging infectious diseases within
healthcare settings is of utmost importance [31]. Early warning
systems and infection control mechanisms were essential for an
efficient global public health response. In 2013, Assiri et al. [2]
warned that human-to-human outbreaks of MERS can occur in
healthcare settings which could be associated with considerable
morbidity. Recent studies have documented and investigated the
outbreaks of MERS in hospitals [4,17,18,22,32]. This study sets
out to estimate the risk of death associated with MERS diseases
between HA-MERS and non HA-MERS, to explore the structures of
transmission networks formed by MERS patients and to investigate
the effects of place of exposure on the risk of deaths from MERS,
whether hospital outbreaks significantly increase length of hospital
stay (LOS). Similarly, we also tested if infected individuals become
super-spreaders because they were exposed in a specific area or
not.
Several studies have reported hospital outbreak of MERS cases
in KSA [2,4,17,32–34], United Arab Emirates [35] and South Korea
[18,23,34]. In this study, we  have identified that, about 48% of
MERS patients with known contact history can be linked to health-
care settings through person-to-person transmission and a large
number of those infected were healthcare workers. The role of theetwork characteristic associated with hospital-acquired Middle
 https://doi.org/10.1016/j.jiph.2018.12.002
patient’s characteristics was explored with network analysis, since
the propagation of the pathogen varies among patients, visitors and
healthcare workers [17]. Some nodes may  amplify the intensity of
disease transmission while others might attenuate the spread [36].
Please cite this article in press as: Adegboye O, et al. Individual and n
East Respiratory Syndrome coronavirus. J Infect Public Health (2018),
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Fig. 2. Visualization of MERS-CoV cases during the outbreak. Isolated cased were not incl
node  sizes implies the more important the patient is.
Table 3
Factors associated (95% confidence limits) with length of hospital stay after the onset
of MERS (N = 787).
Risk factors Effect 95% confidence limits P-value
Lower Upper
Agea −0.045 −0.135 0.061 0.4241
Gender (male) −1.801 −5.118 1.692 0.2878
HA-MERS (yes) 6.133 −0.626 14.724 0.0725
Comorbidity (true) 4.976b 0.294 9.247 0.0306
HCW (yes) −3.322 −8.222 2.499 0.1844
Hospitalized patients −0.258 −7.336 6.819 0.943
Hospital visitors −6.9332 −8.475 9.065 0.9474
Degree centralityc −1.033 −3.010 1.008 0.3061
Betweenness centralityc 0.899 −2.833 1.904 0.6368
Eigenvector centralityc 9.548 −21.116 15.645 0.5421
a A 1-year increase in age.
b Statistical significant at 5% level.
c A unit increase in centrality metrics.
Table 4
Odds ratio and the 95% confidence limits of risk of death associated with MERS disease (i
Risk factors Odds ratio 
Gender: male vs. female 1.413 
Comorbidity true vs. false 2.432f
Healthcare worker true vs. false 0.085f
Hospitalized patient yes vs. no 29.93f
Hospital visitors yes vs. no 0.095f
HA-MERS (yes vs. no) 2.392 
Agea 1.028f
Length of stay 1-dayb 0.981f
Length of stay 7-dayc 0.873f
Length of stay 14-dayd 0.763f
Degree centralitye 0.882 
a 1-year increase in age.
b 1-day increase in length of hospital stay.
c 7-day increase in length of hospital stay.
d 14-day increase in length of hospital stay.
e Unit increase in degree centrality metric.
f Statistical significant at 5% level.uded in the figure. The size of the node represents the degree centrality, increasing
Although most of the patients in this study had comorbidity, they
did not significantly amplify the spread of the disease. On the con-
trary, hospitalized patients with comorbidity had a higher risk of
spreading the disease.
Older patients were more likely to have a hospital-acquired
MERS infection than non-hospital-acquired MERS infections. Older
people seem to have been statistically more exposed to the dis-
ease at healthcare facilities than at other places which might be
the result of a combination of senior people been admitted to the
hospital more frequently due to their advanced age and having less
active social interactions than younger people. This is consistent
with previous findings that the chances of dying from the MERS
grew with increasing age beyond 25 years [10]. It also confirmsetwork characteristic associated with hospital-acquired Middle
 https://doi.org/10.1016/j.jiph.2018.12.002
the common assumption that the danger of infection is greater for
senior patients and, therefore, special attention needs to be paid to
them.
ncluding patients who died during hospital stay) (N = 787).
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Table 5
Odds ratio and the 95% confidence limits of risk of death associated with MERS disease for a 1-day increase in length of hospital stay (N = 787).
Model Risk factors Odds ratio 95% confidence limits






















































n1 Adjusted for age 
2  Adjusted for age + comorbidity 
3  Model 2 + Healthcare worker
The risk of death associated with increased length of stay was
ignificantly higher for patients with comorbidities and hospital-
cquired MERS infections. The impact of MERS infection together
ith another disease or condition was investigated earlier. Such a
ombination was much more likely to be fatal [10,37]. This result
s insofar important as it applies to a large portion of the popula-
ion given the fact that many were affected by non-communicable
iseases of affluence such as diabetes, obesity, heart diseases, etc.
or instance, more than half of the population of Saudi Arabia with
he age of at least 50 years has diabetes [38].
Our analysis has revealed that patients with a hospital-acquired
ERS infection experienced a significantly longer hospital stay and
ere associated with a higher risk of death from the disease. This
ight be closely linked to the second outcome, because the group
f hospital-acquired infections included patients who  had already
een hospitalized for other health issues. The length of hospital
tay has been investigated from various perspectives both medical
nd economical [39–42]. Our result is in accordance with Glance
t al. [43], who showed that the length of hospital stay, associ-
ted costs and mortality rate of hospital-acquired infections were
ignificantly higher for trauma patients. We  tested the correla-
ion of centrality metrics with each other and other patient’s level
haracteristics. All but the eigenvector and betweenness showed
ignificant association, a property which might be less evident for
omplicated networks [44].
Many studies indicate that healthcare workers are at greater
isk of MERS infection [10,12–14,33]. However, we found health-
are workers who were at the receiving end of MERS infections to
ct as epidemic attenuator. Health care workers are often in com-
liance with risk management approaches to reduce and control
ransmission of MERS by wearing protective gears and are aware
f other hygienic measures, to reduce the dose of infectious agents
reventing further spread of the disease. In the same vein, hospi-
alized patients played the role of an epidemic amplifier, i.e. they
layed more the role of transmitters. This complements an earlier
ublication showing that the vast majority of documented MERS
atients had contacts with other patients in healthcare facilities
nd that nosocomial infections occurred more often in outbreak
han non-outbreak cases [15,16].
imitations
We  acknowledge the following limitations in our study. Firstly,
his analysis was  based on retrospective study of publicly available
ata collected from multiple sources; the accuracy of some of the
nformation provided by the patient may  not be verifiable espe-
ially during the early outbreaks. However, the reporting has been
mproved upon over the years with coordination between Saudi
overnment agencies and WHO. The data sets were also assessed
or accuracies with those reported by Flu Trackers, Saudi MOH
nd WHO. Secondly, the network analysis considered in this study
as solely based on confirmed MERS cases with strict direction-
lity; therefore, unconfirmed cases will be missed. Similarly, wePlease cite this article in press as: Adegboye O, et al. Individual and n
East Respiratory Syndrome coronavirus. J Infect Public Health (2018),
estricted our analysis to those with known contact history to be
ble to differentiate the source of infection and construct the trans-
ission network. In spite of these limitations, analysis based on
etwork analysis offers very interesting findings on the distribu- 1.0010 1.0475
 1.2986 14.9797
 0.0235 0.2114
tion of secondary cases caused by each primary case. Lastly, lack of
information on hospitals prevented us from exploring the spread
of MERS between hospitals.
Conclusions
During infectious disease outbreaks, networks of infected indi-
viduals may  be formed depending on the nature of the pathogen’s
transmission. The mechanisms of the transmission and the struc-
ture of the networks need to be well-understood in order to
optimize preventive measures, and have reliable early warning
systems as well as effective treatment methods. The outcomes
of our research emphasize the importance of putting patients
with communicable diseases, especially life-threatening diseases,
immediately under quarantine and minimizing the access of
healthcare workers to such patients. Such precautionary measures
could be lifesaving, in particular for patients with comorbidi-
ties and/or of senior age who  need to be observed closer during
their entire hospital stay. Moreover, healthcare workers should be
advised on their potential role as hubs for pathogens due to the
nature of their occupation. Loose adherences to preventive and pro-
tective measures by the health care workers should be identified
and immediately corrected in order to avoid the negative role they
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